Self-Administered Treatment
Self-administered treatment refers to medical interventions where patients manage the delivery or administration of therapeutic agents without direct, continuous clinical supervision. This approach is increasingly relevant in chronic-disease-management, palliative-care, and experimental oncology contexts.
Key Concepts
- Patient Autonomy: Empowers individuals to take control of their therapeutic regimen.
- Risk Profile: Requires rigorous patient education to mitigate risks of improper dosing, contamination, or adverse reactions.
- Technological Enablers: Relies on simplified delivery mechanisms (e.g., oral formulations, auto-injectors) and digital health monitoring.
Notable Case Studies
- Self-Administered Oncolytic Virotherapy in Recurrent Breast Cancer: Dr. Halassy’s Case
- Context: Dr. Beata Halassy, a Croatian virologist, utilized self-administered oncolytic virotherapy after her aggressive breast cancer recurred multiple times despite conventional surgery and chemotherapy.
- Source: Self-Administered Oncolytic Virotherapy in Recurrent Breast Cancer: Dr. Halassy’s Case
- Significance: Highlights the potential of oncolytic-virotherapy as a self-managed experimental intervention in recurrent-cancer scenarios.
Related Concepts
- Informed-Consent
- Home-Healthcare
- Experimental-Medicine
- Patient-Advocacy